Cargando…

Research and progress on ClC-2

Chloride channel 2 (ClC-2) is one of the nine mammalian members of the ClC family. The present review discusses the molecular properties of ClC-2, including CLCN2, ClC-2 promoter and the structural properties of ClC-2 protein; physiological properties; functional properties, including the regulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongwei, Xu, Minghui, Kong, Qingjie, Sun, Peng, Yan, Fengyun, Tian, Wenying, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482133/
https://www.ncbi.nlm.nih.gov/pubmed/28534947
http://dx.doi.org/10.3892/mmr.2017.6600
_version_ 1783245523521634304
author Wang, Hongwei
Xu, Minghui
Kong, Qingjie
Sun, Peng
Yan, Fengyun
Tian, Wenying
Wang, Xin
author_facet Wang, Hongwei
Xu, Minghui
Kong, Qingjie
Sun, Peng
Yan, Fengyun
Tian, Wenying
Wang, Xin
author_sort Wang, Hongwei
collection PubMed
description Chloride channel 2 (ClC-2) is one of the nine mammalian members of the ClC family. The present review discusses the molecular properties of ClC-2, including CLCN2, ClC-2 promoter and the structural properties of ClC-2 protein; physiological properties; functional properties, including the regulation of cell volume. The effects of ClC-2 on the digestive, respiratory, circulatory, nervous and optical systems are also discussed, in addition to the mechanisms involved in the regulation of ClC-2. The review then discusses the diseases associated with ClC-2, including degeneration of the retina, Sjögren's syndrome, age-related cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus. It was concluded that future investigations of ClC-2 are likely to be focused on developing specific drugs, activators and inhibitors regulating the expression of ClC-2 to treat diseases associated with ClC-2. The determination of CLCN2 is required to prevent and treat several diseases associated with ClC-2.
format Online
Article
Text
id pubmed-5482133
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-54821332017-06-28 Research and progress on ClC-2 Wang, Hongwei Xu, Minghui Kong, Qingjie Sun, Peng Yan, Fengyun Tian, Wenying Wang, Xin Mol Med Rep Review Chloride channel 2 (ClC-2) is one of the nine mammalian members of the ClC family. The present review discusses the molecular properties of ClC-2, including CLCN2, ClC-2 promoter and the structural properties of ClC-2 protein; physiological properties; functional properties, including the regulation of cell volume. The effects of ClC-2 on the digestive, respiratory, circulatory, nervous and optical systems are also discussed, in addition to the mechanisms involved in the regulation of ClC-2. The review then discusses the diseases associated with ClC-2, including degeneration of the retina, Sjögren's syndrome, age-related cataracts, degeneration of the testes, azoospermia, lung cancer, constipation, repair of impaired intestinal mucosa barrier, leukemia, cystic fibrosis, leukoencephalopathy, epilepsy and diabetes mellitus. It was concluded that future investigations of ClC-2 are likely to be focused on developing specific drugs, activators and inhibitors regulating the expression of ClC-2 to treat diseases associated with ClC-2. The determination of CLCN2 is required to prevent and treat several diseases associated with ClC-2. D.A. Spandidos 2017-07 2017-05-18 /pmc/articles/PMC5482133/ /pubmed/28534947 http://dx.doi.org/10.3892/mmr.2017.6600 Text en Copyright: © Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Wang, Hongwei
Xu, Minghui
Kong, Qingjie
Sun, Peng
Yan, Fengyun
Tian, Wenying
Wang, Xin
Research and progress on ClC-2
title Research and progress on ClC-2
title_full Research and progress on ClC-2
title_fullStr Research and progress on ClC-2
title_full_unstemmed Research and progress on ClC-2
title_short Research and progress on ClC-2
title_sort research and progress on clc-2
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482133/
https://www.ncbi.nlm.nih.gov/pubmed/28534947
http://dx.doi.org/10.3892/mmr.2017.6600
work_keys_str_mv AT wanghongwei researchandprogressonclc2
AT xuminghui researchandprogressonclc2
AT kongqingjie researchandprogressonclc2
AT sunpeng researchandprogressonclc2
AT yanfengyun researchandprogressonclc2
AT tianwenying researchandprogressonclc2
AT wangxin researchandprogressonclc2